Gonzalez M I, Robins D M
Department of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan 48109-0618, USA.
J Biol Chem. 2001 Mar 2;276(9):6420-8. doi: 10.1074/jbc.M008689200. Epub 2000 Nov 28.
Gene regulation by steroid hormone receptors depends on the particular character of the DNA response element, the array of neighboring transcription factors, and recruitment of coactivators that interface with the transcriptional machinery. We are studying these complex interactions for the androgen-dependent enhancer of the mouse sex-limited protein (Slp) gene. This enhancer has, in addition to multiple androgen receptor (AR)-binding sites, a central region (FPIV) with a binding site for the ubiquitous transcription factor Oct-1 that appears crucial for hormonal regulation in vivo. To examine the role of Oct-1 in androgen-specific gene activation, we tested the interaction of Oct-1 with AR versus glucocorticoid receptor (GR) in vivo and in vitro. Oct-1 coimmunoprecipitated from cell lysates with both AR and GR, but significant association with AR required both proteins to be DNA-bound. This was confirmed by sensitivity of the protein association to treatment with ethidium bromide or micrococcal nuclease. Addition of DNA to micrococcal nuclease-treated samples restored interaction, even when binding sites were on separate DNA molecules, suggesting association was due to direct protein-protein interaction and not indirect tethering via the DNA. AR/GR chimeras revealed that interaction of the N and C termini of AR was required to communicate the DNA-bound state that enhances interaction with Oct-1. Protease digestion assays of hormone-bound receptors revealed further conformational changes in the ligand binding domain of AR, but not GR, upon DNA binding. Furthermore, these conformational changes led to increased interaction with the coactivator SRC-1, via the NID 4 domain, suggesting DNA binding facilitates recruitment of SRC-1 by the AR-Oct-1 complex. Altogether, these results suggest that the precise arrangement of binding sites in the Slp enhancer ensures proper hormonal response by imposing differential interactions between receptors and Oct-1, which in turn contributes to SRC-1 recruitment to the promoter.
类固醇激素受体对基因的调控取决于DNA反应元件的特定特征、相邻转录因子的组合以及与转录机制相互作用的共激活因子的募集。我们正在研究小鼠性别限制蛋白(Slp)基因雄激素依赖性增强子的这些复杂相互作用。除了多个雄激素受体(AR)结合位点外,该增强子还有一个中央区域(FPIV),其中有一个普遍存在的转录因子Oct-1的结合位点,该位点似乎对体内激素调节至关重要。为了研究Oct-1在雄激素特异性基因激活中的作用,我们在体内和体外测试了Oct-1与AR和糖皮质激素受体(GR)的相互作用。Oct-1可从细胞裂解物中与AR和GR共免疫沉淀,但与AR的显著结合需要两种蛋白质都与DNA结合。用溴化乙锭或微球菌核酸酶处理后蛋白质结合的敏感性证实了这一点。向经微球菌核酸酶处理的样品中添加DNA可恢复相互作用,即使结合位点在不同的DNA分子上,这表明这种结合是由于直接的蛋白质-蛋白质相互作用,而不是通过DNA的间接连接。AR/GR嵌合体表明,AR的N端和C端相互作用对于传递增强与Oct-1相互作用的DNA结合状态是必需的。对激素结合受体的蛋白酶消化分析表明,DNA结合后,AR的配体结合域发生了进一步的构象变化,而GR没有。此外,这些构象变化通过NID 4结构域导致与共激活因子SRC-1的相互作用增加,这表明DNA结合促进了AR-Oct-1复合物对SRC-1的募集。总之,这些结果表明,Slp增强子中结合位点的精确排列通过在受体和Oct-1之间施加差异相互作用来确保适当的激素反应,这反过来又有助于SRC-1募集到启动子上。